A Science Day will be held on June 2, 2026, in MDL 3163 (Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Non-Arteritic Anterior Ischemic Optic Neuropathy Products Liability Litigation)
While tirzepatide is currently approved for weight management and type 2 diabetes, the migraine data opens a conversation about potential off-label applications
Other times, theyre just habitual
In a 2023 paper published in the Annals of the Rheumatic Diseases, Zhu and colleagues identified individuals with knee OA and comorbid type 2 diabetes mellitus from a cohort of more than 40,000 participants in the Shanghai Osteoarthritis Cohort study
His answer, in short, is that they can be something close to a miracle for the right person, and that they are nowhere near ready to be dropped in the drinking water
& Magdy, Y